<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00936260</url>
  </required_header>
  <id_info>
    <org_study_id>individual reseacher</org_study_id>
    <nct_id>NCT00936260</nct_id>
  </id_info>
  <brief_title>Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis</brief_title>
  <official_title>Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ciudad Universitaria, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ciudad Universitaria, Spain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the duration of the treatment with alendronate in
      postmenopausal women with osteoporosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The duration of the treatment with alendronate is not well established. The investigators
      recruited 228 women with postmenopausal osteoporosis. They all received alendronate during
      the first 3 years of monitoring and were later on randomized to whether different regimens of
      intermittent treatment or to carry on 3 years more.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1998</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>Every year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fractures</measure>
    <time_frame>Every year</time_frame>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">228</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>alendronate 6 years</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>alendronate 5 years</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during year 6th</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alendronate 5 years, not continued</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during year 5th</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alendronate 4 years</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during year 5th and 6th</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alendronate 5 years, uncontinued</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during year 4th</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alendronate 4 years, not continued</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during year 4th and 6th</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alendronate 4 years, uncontinued</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during year 4th and 5th</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alendronato 3 years</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No treatment during the last 3 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>alendronate</intervention_name>
    <description>several duration of treatment</description>
    <arm_group_label>alendronate 6 years</arm_group_label>
    <arm_group_label>alendronate 5 years</arm_group_label>
    <arm_group_label>alendronate 5 years, not continued</arm_group_label>
    <arm_group_label>alendronate 4 years</arm_group_label>
    <arm_group_label>alendronate 5 years, uncontinued</arm_group_label>
    <arm_group_label>alendronate 4 years, not continued</arm_group_label>
    <arm_group_label>alendronate 4 years, uncontinued</arm_group_label>
    <arm_group_label>Alendronato 3 years</arm_group_label>
    <other_name>fosamax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  postmenopausal osteoporosis under densitometric criteria of the World Health
             Organization

        Exclusion Criteria:

          -  secondary osteoporosis

          -  alteration in analytic parameters (total proteins, calcium, phosphorus, vitamin D,
             parathyroid hormone, thyroid hormone, transaminase, creatinine)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Lozano Tonkin, doctor</last_name>
    <role>Study Director</role>
    <affiliation>university san carlos hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University San Carlos Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 1998</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2009</study_first_submitted>
  <study_first_submitted_qc>July 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2009</study_first_posted>
  <last_update_submitted>July 9, 2009</last_update_submitted>
  <last_update_submitted_qc>July 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Esther Alvarez-Rodriguez</name_title>
    <organization>University San Carlos Hospital</organization>
  </responsible_party>
  <keyword>osteoporosis</keyword>
  <keyword>postmenopausal</keyword>
  <keyword>alendronate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alendronate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

